It is important for regulatory clinical trials for ulcerative colitis to acknowledge that concomitant exposure to common medications does not affect UC treatment efficacy or safety. Concomitant use of ...
Baseline characteristics of patients with PSMA-PET–positive and –negative disease with high-risk of biochemical recurrence (BCR) after radical prostatectomy (RP) in the ongoing phase 3 PRIMORDIUM ...
Presurgical treatment for inferior vena cava tumor thrombus in patients with renal cell carcinoma: A scoping review. Univariate analysis of survival outcomes and clinical benefit.
Immunomodulatory drug users were significantly less likely to discontinue pegloticase compared to non-users with no additional concerning lab or safety findings. Concomitant immunomodulatory drug use ...
To evaluate the weight loss outcomes of the large U.S. cohort of patients undergoing endoscopic sleeve gastroplasty (ESG) with or without concomitant anti-obesity (AOM) use. We performed a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results